Sep 29, 2017
85:83
For every 83 shares held, investors received 85. The price per share adjusted from $0.02 to $0.02.
The split itself did not change the total investment value.
Avecho Biotechnology Limited (ASX:AVE) operates in the Pharmaceuticals: major industry.
Avecho Biotechnology Limited company overviewAvecho Biotechnology Limited's most recent stock split was on September 29, 2017. It was a 85-for-83 forward split, so shareholders received 85 shares for every 83 they held.
Avecho Biotechnology Limited (ASX:AVE) has split its stock 2 times: a 968-for-721 split on April 23, 1999 and a 85-for-83 split on September 29, 2017.
Avecho Biotechnology Limited has split its stock 2 times. This history records 2 forward splits between April 23, 1999 and September 29, 2017.
A stock split divides each share into more shares and lowers the price per share by the same factor, so the total value of a holding does not change. In Avecho Biotechnology Limited's 85-for-83 split on September 29, 2017, every 83 shares became 85 shares.
Avecho Biotechnology Limited has not announced a new split in our records. Its most recent split was on September 29, 2017, 9 years ago. Companies announce splits in advance, and any new ASX:AVE split will appear on this page.
Already premium?